- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
Lotus Pharmaceutical
Market Cap: NT$75.2b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$286.00
7D
-1.7%
1Y
13.7%
PharmaEngine
Market Cap: NT$9.6b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$66.80
7D
-3.2%
1Y
-34.5%
TTY Biopharm
Market Cap: NT$19.7b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$79.30
7D
-3.1%
1Y
8.2%